Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

Phase 3

• Conditions: Giving a Vaccination in Three Months

• Registration Number: NCT01281072
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

Open label study to evaluate long term treatment effect of diapep277.

Detailed Description

Not available

Study Timeline

• Status Verified: 2011-01
• Study First Submitted: 2011-01-20
• Study First Submitted QC: 2011-01-20
• Last Update Submitted: 2011-01-20
• Study First Posted: 2011-01-21
• Last Update Posted: 2011-01-21

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. patient that completed 901 and 910 study.

Exclusion Criteria

1. cpeptide<0.2

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
c peptide reserve